MedPath

Investigation of the Effects of Short Foot Exercise and Mobilization in Young Adults With Pes Planus

Not Applicable
Not yet recruiting
Conditions
Pes Planus
Registration Number
NCT07107763
Lead Sponsor
Kirsehir Ahi Evran Universitesi
Brief Summary

Pes Planus (PP) is a foot deformity characterized by a lower-than-normal medial longitudinal arch. Individuals diagnosed with PP experience various challenges in daily life. Among these challenges are limitations in balance and movement skills. To reduce the effects of PP, several treatment approaches are preferred. These interventions are generally categorized into surgical and conventional treatments. Among conservative approaches, the short foot exercise is one of the most fundamental and commonly used methods. This exercise aims to strengthen the intrinsic muscles of the foot to support the arch. In addition to the short foot exercise, other exercises such as towel scrunching and toe spreading are also used in the management of PP. However, when looking at the treatment options for PP, studies examining the use and effects of joint mobilization are limited. The present study aims to investigate the effects of subtalar joint mobilization, short foot exercises, and the combined application of these interventions in individuals with PP. This approach is based on findings that subtalar joint mobilization has positive effects on balance in individuals with balance impairments.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
45
Inclusion Criteria
  • To be diagnosed with flexible pes planus
Exclusion Criteria
  • Having other comorbidities

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Vertical Jump TestFrom enrollment to the end of treatment at 6 weeks
Shuttle Run TestFrom enrollment to the end of treatment at 6 weeks
Secondary Outcome Measures
NameTimeMethod
Standing Broad Jump TestFrom enrollment to the end of treatment at 6 weeks
Biodex Balance AssessmentFrom enrollment to the end of treatment at 6 weeks

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.